Docking and quantum mechanic studies on cholinesterases and their inhibitors

被引:53
作者
Correa-Basurto, Jose
Flores-Sandoval, Cesar
Marin-Cruz, Jesus
Rojo-Dominguez, Arturo
Espinoza-Fonseca, L. Michel
Trujillo-Ferrara, Jose G.
机构
[1] Inst Politecn Nacl, Secc Grad, Mexico City 11340, DF, Mexico
[2] Inst Politecn Nacl, Dept Bioquim, Escuela Super Med, Mexico City 11340, DF, Mexico
[3] Inst Politecn Nacl, Dept Farmacol, Escuela Super Med, Mexico City 11340, DF, Mexico
[4] Inst Mexicano Petr, Programa Ingn Mol, Mexico City 07730, DF, Mexico
[5] Univ Autonoma Metropolitana Iztapalapa, Dept Quim, Unidad Iztapalapa & Ciencias Nat, Unidad Cuajimalpa, Mexico City 09340, DF, Mexico
[6] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA
关键词
Alzheimer's disease; butyrylcholinesterase; acetylcholinesterase; N-aryl derivatives; HOMO-LUMO densities; docking;
D O I
10.1016/j.ejmech.2006.08.015
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Docking studies and density functional theory (DFT) calculations were made for 88 N-aryl derivatives and for some acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) residues. Based on this information, some compounds were synthesized and tested kinetically in vitro as AChE inhibitors. Finally, some chemical properties of the N-aryl derivatives were calculated: partition coefficient (it) and molecular electrostatic potentials (MESPs) whereas their electronic effects (rho) were taken from the literature. The results showed that all compounds act inside the AChE gorge, making pi-pi interactions and hydrogen bonds with Trp86 and Ser203 and by high HOMO energies of Ser2003 and high LUMO energies of N-aryl derivatives. These theoretical calculations for AChE are in agreement with the experimental data, whereas such calculations for BChE do not show the same behavior which could be due to in spite of both cholinesterase enzymes displaying similar functional activities they do possess important structural differences at their catalystic sites. (c) 2006 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:10 / 19
页数:10
相关论文
共 51 条
[21]   Pyridophens: Binary pyridostigmine-aprophen Prodrugs with differential inhibition of acetylcholinesterase, butyrylcholinesterase, and muscarinic receptors [J].
Leader, H ;
Wolfe, AD ;
Chiang, PK ;
Gordon, RK .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) :902-910
[22]   Theoretical insights into the mechanism of acetylcholinesterase-catalyzed acylation of acetylcholine [J].
Manojkumar, TK ;
Cui, CZ ;
Kim, KS .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2005, 26 (06) :606-611
[23]  
Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO
[24]  
2-B
[25]   Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase -: Expression, purification, characterization and crystallization [J].
Nachon, F ;
Nicolet, Y ;
Viguié, N ;
Masson, P ;
Fontecilla-Camps, JC ;
Lockridge, O .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (02) :630-637
[26]  
Nachon Fl., 2005, Annales Pharmaceutiques Francaises, V63, P194, DOI 10.1016/S0003-4509(05)82274-6
[27]   Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products [J].
Nicolet, Y ;
Lockridge, O ;
Masson, P ;
Fontecilla-Camps, JC ;
Nachon, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (42) :41141-41147
[28]   EFFECTIVE CHARGE ON ACETYLCHOLINESTERASE ACTIVE-SITES DETERMINED FROM THE IONIC-STRENGTH DEPENDENCE OF ASSOCIATION RATE CONSTANTS WITH CATIONIC LIGANDS [J].
NOLTE, HJ ;
ROSENBERRY, TL ;
NEUMANN, E .
BIOCHEMISTRY, 1980, 19 (16) :3705-3711
[29]   Electrostatic influence on the kinetics of ligand binding to acetylcholinesterase - Distinctions between active center ligands and fasciculin [J].
Radic, Z ;
Kirchhoff, PD ;
Quinn, DM ;
McCammon, JA ;
Taylor, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (37) :23265-23277
[30]   Acetylcholinesterase inhibitors:: Synthesis and structure-activity relationships of ω-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)methyl] aminoalkoxyheteroaryl derivatives [J].
Rampa, A ;
Bisi, A ;
Valenti, P ;
Recanati, M ;
Cavalli, A ;
Andrisano, V ;
Cavrini, V ;
Fin, L ;
Universi, GDOS ;
Buriani, A ;
Giusti, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (21) :3976-3986